Sharing is Caring: The Case for Company-Level Collaboration in Pharmacoeconomic Modelling

Sharing is Caring: The Case for Company-Level Collaboration in Pharmacoeconomic Modelling PharmacoEconomics (2017) 35:755–757 DOI 10.1007/s40273-017-0516-2 COMMENTARY Sharing is Caring: The Case for Company-Level Collaboration in Pharmacoeconomic Modelling 1,2 3,4 Anthony J. Hatswell Fleur Chandler Published online: 20 May 2017 Springer International Publishing Switzerland 2017 In the recent National Institute for Health and Care being ethically superior by making better use of patient Excellence (NICE) appraisals for rheumatoid arthritis, the input. We will discuss each of these areas in turn, as well as six companies involved each independently conducted where collaboration is most likely to be advantageous. systematic reviews, economic modelling and network Should a model be developed collaboratively by multi- meta-analyses [1]. Each will have incurred substantial ple companies, it would receive a much larger degree of agency fees and internal time to manage the projects. scrutiny. While this may take longer to achieve a final Given the models were also based on a very similar version, it also means mistakes are less likely to survive the structure, each needed to solve very similar problems (in- process. With multiple companies also collaborating on dependently) from the perspective of disease progression. model design, the resulting model is also more likely to This is a typical situation, with examples ranging from http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png PharmacoEconomics Springer Journals

Sharing is Caring: The Case for Company-Level Collaboration in Pharmacoeconomic Modelling

Loading next page...
 
/lp/springer_journal/sharing-is-caring-the-case-for-company-level-collaboration-in-Pi0vZVSOf0
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing Switzerland
Subject
Medicine & Public Health; Pharmacoeconomics and Health Outcomes; Quality of Life Research; Health Economics; Health Administration; Public Health
ISSN
1170-7690
eISSN
1179-2027
D.O.I.
10.1007/s40273-017-0516-2
Publisher site
See Article on Publisher Site

Abstract

PharmacoEconomics (2017) 35:755–757 DOI 10.1007/s40273-017-0516-2 COMMENTARY Sharing is Caring: The Case for Company-Level Collaboration in Pharmacoeconomic Modelling 1,2 3,4 Anthony J. Hatswell Fleur Chandler Published online: 20 May 2017 Springer International Publishing Switzerland 2017 In the recent National Institute for Health and Care being ethically superior by making better use of patient Excellence (NICE) appraisals for rheumatoid arthritis, the input. We will discuss each of these areas in turn, as well as six companies involved each independently conducted where collaboration is most likely to be advantageous. systematic reviews, economic modelling and network Should a model be developed collaboratively by multi- meta-analyses [1]. Each will have incurred substantial ple companies, it would receive a much larger degree of agency fees and internal time to manage the projects. scrutiny. While this may take longer to achieve a final Given the models were also based on a very similar version, it also means mistakes are less likely to survive the structure, each needed to solve very similar problems (in- process. With multiple companies also collaborating on dependently) from the perspective of disease progression. model design, the resulting model is also more likely to This is a typical situation, with examples ranging from

Journal

PharmacoEconomicsSpringer Journals

Published: May 20, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off